ERBB2 and neoplasm: In GEA HER2 status ctDNA testing, also known as ‘liquid biopsy’, may be evaluated by circulating tumor cells (CTCs) and at least one CTC (CTC ≥1) has been detected in 73.5% of GEA samples [101,102,103,104,105,106,107,108].